BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33573922)

  • 1. The appropriateness of thyroid lobectomy as an initial surgery for preoperatively detected unilateral multifocal papillary carcinoma.
    Albinsaad LS; Kim WW; Lee YM; Sung TY; Chung KW; Hong SJ
    Asian J Surg; 2021 Aug; 44(8):1050-1055. PubMed ID: 33573922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
    Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
    World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
    Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
    JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
    Beom Heo D; Piao Y; Hee Lee J; Ju SH; Yi HS; Su Kim M; Won HR; Won Chang J; Seok Koo B; Eun Kang Y
    Oral Oncol; 2022 Nov; 134():106115. PubMed ID: 36108524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma.
    Huang H; Liu S; Xu Z; Ni S; Zhang Z; Wang X
    Medicine (Baltimore); 2017 Jul; 96(27):e7461. PubMed ID: 28682915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
    Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
    Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
    Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
    Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
    Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
    Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
    Ryu YJ; Cho JS; Yoon JH; Park MH
    World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
    Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
    Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.
    Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ
    Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients.
    Suh YJ; Kwon H; Kim SJ; Choi JY; Lee KE; Park YJ; Park DJ; Youn YK
    Ann Surg Oncol; 2015 Oct; 22(11):3543-9. PubMed ID: 25743326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma.
    Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Front Endocrinol (Lausanne); 2022; 13():1060301. PubMed ID: 36686467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of intra-operative frozen section for the evaluation of microscopic extrathyroidal extension in papillary thyroid carcinoma.
    Hong JC; Seo JW; Jang AL; Suh SH; Pak MG; Han SH; Park YJ; Lee DK; Park HS; Kang MK
    Clin Otolaryngol; 2017 Dec; 42(6):1167-1171. PubMed ID: 28166397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of Patients with 1-4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles.
    Jang A; Jin M; Kim WW; Jeon MJ; Sung TY; Song DE; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
    Ann Surg Oncol; 2022 Nov; 29(12):7835-7842. PubMed ID: 35907995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.